IDSA Responds to FDA authorization of Second Booster

FDA’s authorization of a second COVID-19 booster shot for individuals 50 and over provides another opportunity for people to increase their level of protection against severe disease, hospitalization and death. 

IDSA calls on Congress to pass another COVID-19 supplemental funding bill to ensure that all individuals can access COVID-19 vaccines, including newly authorized boosters, as well as COVID-19 tests and therapeutics. The bill should also include the resources necessary for global COVID-19 vaccination and response in order to prevent the development and spread of new variants.

Vaccination remains a critical tool to end the pandemic, and IDSA strongly encourages all individuals to stay up to date on their vaccinations.

Daniel P. McQuillen, MD, FIDSA – President, Infectious Diseases Society of America

About IDSA
The Infectious Diseases Society of America (IDSA) is a community of over 12,000 physicians, scientists and public health experts who specialize in infectious diseases. Its purpose is to improve the health of individuals, communities and society by promoting excellence in patient care, education, research, public health and prevention relating to infectious diseases. Learn more at https://www.idsociety.org/.